Bright Peak Therapeutics Appoints Jacob Chacko, M.D., as Chair of its Board of Directors
SAN DIEGO and BASEL, Switzerland, Nov. 29, 2021 (GLOBE NEWSWIRE) — Bright Peak Therapeutics, a biotechnology company developing next-generation cytokine immunotherapies to treat cancer and